We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
63 hedge funds and large institutions have $109M invested in Regulus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
180% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 10
176% more call options, than puts
Call options by funds: $329K | Put options by funds: $119K
40% more funds holding
Funds holding: 45 → 63 (+18)
14.11% more ownership
Funds ownership: 79.56% → 93.68% (+14%)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
26% less capital invested
Capital invested by funds: $147M → $109M (-$37.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
63
Holders Change
+18
Holders Change %
+40%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
28
Increased
13
Reduced
14
Closed
10
Calls
$329K
Puts
$119K
Net Calls
+$210K
Net Calls Change
-$739K
Top Buyers
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$9.9M |
| 2 |
BlackRock
New York
|
+$9.05M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.68M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.03M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.72M |
